인쇄하기
취소
|
Hanmi Pharm will drastically strengthen sales, marketing and R&D on the ophthalmologic field.
On the 23rd, Hanmi Pharm(CEO Kwan-soon Lee) announced reorganization of the ophthalmologic department and investment of 730 people into sales and marketing for the field.
Previously, the Hanmi’s ophthalmologic business was only handled by about 30 personnel as categorized as a special sales section...